Sanofi SA vs United States Natural Gas Fund — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while United States Natural Gas Fund trades at $10.4. The key difference: Sanofi SA pays a 5.5% dividend while United States Natural Gas Fund pays none, and Sanofi SA is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| SNY | UNG | |
|---|---|---|
Market Cap | $104.83B | — |
Sector | Health | Commodities - Energy |
52-Week High | $52.34 | $16.90 |
52-Week Low | $41.33 | $10.15 |
Enterprise Value | $121.32B | — |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →